Blood-based methods for determining Aβ amyloidosis
US12066444B2 · kind B2 · utility
0Cited by
0References
8Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | May 1, 2018 |
| Grant date | Aug 20, 2024 |
| Priority date | — |
| Expiry date | May 1, 2038 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/4709
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present disclosure provides methods for blood-based examination useful to identify subjects with Aβ amyloidosis and/or to identify subjects who should or should not undergo further testing or treatment for Aβ amyloidosis, as well as methods for treating subjects diagnosed with Aβ amyloidosis by the methods disclosed herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.